Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Paternal Age
NCT: NCT07605182 · NOT_YET_RECRUITING
Brief Summary
Male infertility contributes significantly to infertility, particularly in advanced paternal age men where sperm DNA fragmentation is increased. Conventional density gradient centrifugation may induce oxidative stress and sperm damage. LensHooke® CA0 is a centrifugation-free sperm sorting device designed to improve sperm quality and reduce DNA fragmentation. This prospective comparative study evaluates the effectiveness of CA0 versus conventional density gradient centrifugation on post-processing sperm quality, DNA fragmentation index, blastocyst formation, euploid embryo rate, and clinical pregnancy outcomes in IVF/ICSI cycles involving men aged 40 years or older
Frequently Asked Questions
What is Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Paternal Age?
Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Paternal Age is a clinical trial registered under NCT07605182. Current status: NOT_YET_RECRUITING.
What is the status of NCT07605182?
The current status of NCT07605182 (Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Paternal Age) is: NOT_YET_RECRUITING.
When did Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Paternal Age start?
Effectiveness of Live Motile Sperm Sorting Device on IVF Outcomes in Advanced Paternal Age started on 2026-05-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.